JPY2,467.50
1.40% today
Tokyo, Nov 26, 07:15 am CET
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Kyowa Kirin Stock price

JPY2,469.50
-95.00 3.70% 1M
-113.50 4.39% 6M
+99.50 4.20% YTD
+36.50 1.50% 1Y
-870.50 26.06% 3Y
+150.50 6.49% 5Y
+1,170.50 90.11% 10Y
Tokyo, Closing price Tue, Nov 26 2024
-33.00 1.32%
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Key metrics

Market capitalization JPY1.28t
Enterprise Value JPY999.69b
P/E (TTM) P/E ratio 15.97
EV/FCF (TTM) EV/FCF 12.82
EV/Sales (TTM) EV/Sales 2.00
P/S ratio (TTM) P/S ratio 2.56
P/B ratio (TTM) P/B ratio 1.57
Dividend yield 2.32%
Last dividend (FY24) JPY58.00
Revenue growth (TTM) Revenue growth 18.62%
Revenue (TTM) Revenue JPY498.98b
EBIT (operating result TTM) EBIT JPY108.14b
Free Cash Flow (TTM) Free Cash Flow JPY78.00b
Cash position JPY296.33b
EPS (TTM) EPS JPY156.66
P/E forward 18.55
P/S forward 2.60
EV/Sales forward 2.04
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Kyowa Kirin forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Kyowa Kirin forecast:

Buy
64%
Hold
36%

Financial data from Kyowa Kirin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
498,977 498,977
19% 19%
100%
- Direct Costs 136,991 136,991
25% 25%
27%
361,986 361,986
16% 16%
73%
- Selling and Administrative Expenses 134,183 134,183
3% 3%
27%
- Research and Development Expense 95,225 95,225
36% 36%
19%
132,578 132,578
29% 29%
27%
- Depreciation and Amortization 24,443 24,443
24% 24%
5%
EBIT (Operating Income) EBIT 108,135 108,135
31% 31%
22%
Net Profit 83,534 83,534
44% 44%
17%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,974
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today